临床荟萃

• 论著 • 上一篇    下一篇

血浆同型半胱氨酸对慢性心力衰竭患者的作用及意义

  

  1. 1.承德医学院,河北 承德  067000;2.保定市第一中心医院 心内科,河北 保定 071000
  • 收稿日期:2016-02-17 出版日期:2016-06-05 发布日期:2016-06-06
  • 通讯作者: 通信作者:田祥,Email:15903126523@163.com

Effect and significance of plasma homocysteine in patients with chronic heart failure

  1. 1.Chengde Medical University,Chengde 067000,China;
    2.Department of Cardiology, the First  Central Hospital, Baoding  071000, China
  • Received:2016-02-17 Online:2016-06-05 Published:2016-06-06
  • Contact: Corresponding author:Tian Xiang,Email: 15903126523@163.com

摘要: 目的 通过观察慢性心力衰竭患者血同型半胱氨酸(Hcy)与B型利钠肽(BNP)的相关性,进一步探讨
测定血Hcy水平对于慢性心力衰竭患者的作用及意义。方法 入选了151例慢性心力衰竭患者作为心力衰竭组,其
中男93例,女58例,年龄27~92岁,平均(66.7±11.6)岁,所有入选患者均抽取空腹肘静脉血,测定血Hcy水平、
BNP浓度、血脂、血糖等。同时入选同期住院的249例心功能正常的患者作为对照组。结果 ①心力衰竭组的血
Hcy水平明显高于对照组(19.90±5.07)μmol/Lvs(14.84±4.87)μmol/L(P <0.01);心力衰竭组的血BNP浓度
明显高于对照组(1851.67±742.59)ng/Lvs(197.52±84.46)ng/L(P <0.01);②血Hcy、BNP随心功能分级的增
加而增加,差异有统计学意义(P <0.01);③血Hcy与BNP呈显著正相关(r =0.629,P <0.01);④Logistic回归分
析显示:高血压(OR =1.826,95%CI =1.021~3.266,P <0.05)、糖尿病(OR =1.716,95%CI =1.020~2.887,
P <0.05)、高脂血症(OR =1.856,95%CI =1.015~3.396,P <0.05)、吸烟(OR =1.952,95%CI =1.233~
3.089,P <0.05)、Hcy(OR =3.743,95%CI =2.271~6.169,P <0.01)为慢性心力衰竭患者的危险因素;⑤血
Hcy诊断慢性心力衰竭的ROC 曲线参数分析显示:AUC 为0.754,95%CI =0.706~0.802,P <0.01,临界值为
17.75μmo/L,敏感度为66.20%,特异度为73.90%。结论 血Hcy为慢性心力衰竭患者的独立危险因素,且临界值,
可作为慢性心力衰竭的新的诊断指标。

关键词: 心力衰竭, 半胱氨酸, 利钠肽,脑, 心功能

Abstract:

ObjectiveTo investigate the role of plasma homocysteine and its clinical significance in chronic heart failure  patients by observing the relationship of plasma homocysteine (Hcy) and B type natriuretic peptide (BNP).MethodsA total of 151 chronic heart failure patients including 93 males and 58 females, average age (66.7±11.6) years were investigated,and  249 patients with normal cardiac function at the same time of hospitalization served as control group.Plasma  Hcy, BNP,lipids, blood glucose were studied.Results①The plasma Hcy concentration in heart failure  patients was significantly higher than control group (19.90±5.07)  μmol/L vs  (14.84±4.87) μmol/L(P<0.01);The serum BNP concentration in heart failure patients was significantly higher than control group (1 851.67±742.59) ng/L vs  (197.5±84.5)  ng/L(P<0.01). ② The plasma Hcy and BNP were different from New York Heart Association (NYHA) classes  (P<0.01). ③ The plasma Hcy and BNP were linear positive correlation (r=0.629,P<0.01). ④The results of logistic regression showed that hypertension (OR=1.826,95%CI=1.0213.266,P<0.05),diabetes (OR=1.716,95%CI=1.0202.887,P<0.05),hyperlipidemia (OR=1.856,95%CI=1.0153.396,P<0.05),smoking (OR=1.952,95%CI=1.2333.089,P<0.05),Hcy(OR=3.743,95%CI=2.2716.169,P<0.01)  were risk factors for patients with chronic heart failure.⑤Receiver operating characteristic curve analysis indicated the cut  off of Hcy for chronic  heart failure was 17.75  μmo/L (ROC area under curve: 0.754,95%CI=0.7060.802,P<0.01) with 73.90% specificity and 66.20%  sensitivity.ConclusionHcy  is an independent risk factor for chronic heart failure, and the cut of value can be used as a new diagnostic index for chronic heart failure.

Key words: heart failure, cysteine, natriuretic , peptide, brain, cardiac function